Results 211 to 220 of about 21,193 (336)

Tales of Cyberspace and Artificial Intelligence: Diverging Stakeholderships?

open access: yesGlobal Policy, EarlyView.
ABSTRACT This article traces the evolution of the Internet from the 1990s to the 2020s and compares it with the development of Artificial Intelligence (AI), particularly following the public launch of ChatGPT in late 2022. It identifies both parallels and divergencies between these two overlapping technological domains, focusing on the growing ...
Johan Eriksson, Giampiero Giacomello
wiley   +1 more source

Audit Committee Networks and Audit Fees: A European Analysis

open access: yesAccounting &Finance, EarlyView.
ABSTRACT This study investigates the association between audit committee member networks and audit fees in a sample of 225 publicly traded firms from eight European countries between 2005 and 2020. Using social network analysis, we find that director interconnections—established through overlapping board memberships—are associated with audit fees.
Ruth García‐Cobo   +2 more
wiley   +1 more source

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials. [PDF]

open access: yesNPJ Precis Oncol
Nichetti F   +20 more
europepmc   +1 more source

Use of Attention Deficit Hyperactivity Disorder Medication Among Danish Children and Adolescents From 2010 to 2023

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Pharmacological treatment is an important component in the multimodal management of attention deficit hyperactivity disorder (ADHD), but contemporary trends in ADHD medication use among boys and girls in Denmark have not been fully characterized.
Maria Højgaard Stoltz‐Andersen   +4 more
wiley   +1 more source

Palbociclib in the Treatment of HR+/ HER2‐ Advanced or Metastatic Breast Cancer in Australia: A Real‐World Retrospective Analysis

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This study investigated the real‐world use of CDK4/6 inhibitors in Australian patients with HR+/HER2‐ advanced or metastatic breast cancer, providing data on patient demographics, treatment patterns, and outcomes with palbociclib. ABSTRACT Background There is limited real‐world data on the use of CDK4/6 inhibitors in Australian patients with HR+/HER2 ...
Louise Nott   +8 more
wiley   +1 more source

Effectiveness and safety of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. [PDF]

open access: yesFront Pharmacol
Roccuzzo G   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy